Brainsway Ltd ADR

BWAYNASDAQ · USD
11.15USD+0.54 (+5.09%)
359

Brainsway Ltd ADR (BWAY) Covered Calls

Brainsway Ltd ADR trades in the Medical Devices industry with an IV Rank of 35.71%, average versus the past year. BWAY's highest covered call setup is the $15.00 strike expiring Jan 15, 2027, sorted by theoretical annualized return. It's 41.38% out of the money with 71 days to expiration, a 42.32% return until expiration, and a 217.55% theoretical annualized return. Across the setups shown, annualized returns run from 217.55% to 217.55% at strikes between $15.00 and $15.00, with 71 to 71 days to expiration, as of Nov 5, 2026.

Read more

Running BWAY covered calls helps you generate income from Brainsway Ltd ADR shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BWAY covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If BWAY stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BWAY covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BWAY covered call is worth writing.

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry.

2027-01-157115.0041.380.100.70449.0042.32217.55-0.94+0.221230.60

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank35.71% Moderate
  • Market cap (M$)427
  • 52 weeks high-39.02%
  • 52 weeks low48.60%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$19.27
    72.83% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-10
  • P/E44.65
  • Future P/E20.94
  • EPS (ttm)0.24
  • EPS growth next 5 years44.22%

As of Nov 5, 2026